Revolade Tablets contain Eltrombopag, a thrombopoietin receptor agonist (TPO-RA) used to increase platelet production in patients with certain blood disorders. It is prescribed under specialist supervision for conditions such as chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA) in approved populations. Indications vary by country, so treatment should always follow local regulatory guidance.
Cordium Pharmaceuticals Pvt. Ltd. is committed to supplying high-quality pharmaceutical products for global markets while complying with applicable regulatory and quality standards.
What Are Revolade Tablets?
Revolade is the brand name for Eltrombopag, an oral thrombopoietin receptor agonist that stimulates platelet production in the bone marrow. It is prescribed to help manage low platelet counts in eligible patients under the supervision of a hematology specialist.
Approved Medical Uses
Depending on the country and regulatory approval, Revolade may be prescribed for:
Chronic Immune Thrombocytopenia (ITP)
Severe Aplastic Anemia (SAA)
Certain patients with thrombocytopenia associated with chronic hepatitis C where specifically approved
Approved indications differ between countries and may change over time. Always consult the local prescribing information.
Available Strengths
Revolade 25 mg Tablets
Revolade 50 mg Tablets
Revolade 75 mg Tablets
Some markets also offer additional strengths or oral suspension formulations.
Benefits of Revolade Tablets
Helps increase platelet counts in eligible patients
Oral tablet formulation for convenient administration
Used under specialist supervision for chronic hematologic disorders
May reduce bleeding risk associated with severe thrombocytopenia in appropriate patients
Supported by clinical evidence in approved indications
Important Safety Information
Revolade should only be used under medical supervision.
Healthcare providers generally monitor:
Platelet counts
Liver function tests
Complete blood counts
Response to treatment and adverse effects
Potential risks include liver toxicity, thromboembolic events, and cataracts in some patients. Dose adjustments are individualized based on platelet response.
Availability in USA, UK, UAE & South Africa
Revolade (Eltrombopag) is available in numerous international markets, including:
USA
Eltrombopag is marketed under different brand names depending on the country. Availability and approved indications are determined by the U.S. regulatory authorities.
United Kingdom
Revolade is an approved prescription medicine for specific hematologic conditions under specialist supervision.
UAE
Availability depends on local regulatory approval and authorized pharmaceutical distributors.
South Africa
Revolade is available as a prescription medicine in accordance with local regulatory approvals.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. focuses on delivering high-quality pharmaceutical products for international markets.
Our Strengths
International pharmaceutical exporter
Quality-focused manufacturing
Wide therapeutic portfolio
Regulatory documentation support
Reliable global supply chain
Customer-focused service
Frequently Asked Questions (FAQs)
1. What is Revolade used for?
Revolade (Eltrombopag) is used to increase platelet counts in patients with approved conditions such as immune thrombocytopenia (ITP) and severe aplastic anemia (SAA), depending on local regulatory approvals.
2. What is the active ingredient in Revolade?
The active ingredient is Eltrombopag.
3. Is Revolade available in the USA?
Eltrombopag is available in the United States, although branding and approved indications may differ from other countries.
4. Can Revolade cure thrombocytopenia?
No. Revolade is intended to help increase platelet counts in eligible patients; it is not considered a cure for the underlying condition.
5. Is Revolade a prescription medicine?
Yes. It should only be used with a valid prescription and under specialist medical supervision.
6. What strengths are available?
Common tablet strengths include:
25 mg
50 mg
75 mg
Availability varies by market.
7. Are there side effects?
Possible side effects include headache, nausea, elevated liver enzymes, and an increased risk of blood clots in some patients. Patients require regular monitoring.
8. Can children take Revolade?
In some countries, Revolade is approved for pediatric patients with specific forms of ITP. Eligibility depends on age, diagnosis, and local prescribing information.
9. Can I buy Revolade online?
Revolade is a prescription-only medicine and should only be obtained through licensed pharmacies and authorized healthcare channels in accordance with local laws.
10. Why choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. aims to provide high-quality pharmaceutical products backed by quality standards, regulatory support, and reliable global distribution
Cordium Pharmaceuticals Pvt. Ltd. is committed to supplying high-quality pharmaceutical products for global markets while complying with applicable regulatory and quality standards.
What Are Revolade Tablets?
Revolade is the brand name for Eltrombopag, an oral thrombopoietin receptor agonist that stimulates platelet production in the bone marrow. It is prescribed to help manage low platelet counts in eligible patients under the supervision of a hematology specialist.
Approved Medical Uses
Depending on the country and regulatory approval, Revolade may be prescribed for:
Chronic Immune Thrombocytopenia (ITP)
Severe Aplastic Anemia (SAA)
Certain patients with thrombocytopenia associated with chronic hepatitis C where specifically approved
Approved indications differ between countries and may change over time. Always consult the local prescribing information.
Available Strengths
Revolade 25 mg Tablets
Revolade 50 mg Tablets
Revolade 75 mg Tablets
Some markets also offer additional strengths or oral suspension formulations.
Benefits of Revolade Tablets
Helps increase platelet counts in eligible patients
Oral tablet formulation for convenient administration
Used under specialist supervision for chronic hematologic disorders
May reduce bleeding risk associated with severe thrombocytopenia in appropriate patients
Supported by clinical evidence in approved indications
Important Safety Information
Revolade should only be used under medical supervision.
Healthcare providers generally monitor:
Platelet counts
Liver function tests
Complete blood counts
Response to treatment and adverse effects
Potential risks include liver toxicity, thromboembolic events, and cataracts in some patients. Dose adjustments are individualized based on platelet response.
Availability in USA, UK, UAE & South Africa
Revolade (Eltrombopag) is available in numerous international markets, including:
USA
Eltrombopag is marketed under different brand names depending on the country. Availability and approved indications are determined by the U.S. regulatory authorities.
United Kingdom
Revolade is an approved prescription medicine for specific hematologic conditions under specialist supervision.
UAE
Availability depends on local regulatory approval and authorized pharmaceutical distributors.
South Africa
Revolade is available as a prescription medicine in accordance with local regulatory approvals.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. focuses on delivering high-quality pharmaceutical products for international markets.
Our Strengths
International pharmaceutical exporter
Quality-focused manufacturing
Wide therapeutic portfolio
Regulatory documentation support
Reliable global supply chain
Customer-focused service
Frequently Asked Questions (FAQs)
1. What is Revolade used for?
Revolade (Eltrombopag) is used to increase platelet counts in patients with approved conditions such as immune thrombocytopenia (ITP) and severe aplastic anemia (SAA), depending on local regulatory approvals.
2. What is the active ingredient in Revolade?
The active ingredient is Eltrombopag.
3. Is Revolade available in the USA?
Eltrombopag is available in the United States, although branding and approved indications may differ from other countries.
4. Can Revolade cure thrombocytopenia?
No. Revolade is intended to help increase platelet counts in eligible patients; it is not considered a cure for the underlying condition.
5. Is Revolade a prescription medicine?
Yes. It should only be used with a valid prescription and under specialist medical supervision.
6. What strengths are available?
Common tablet strengths include:
25 mg
50 mg
75 mg
Availability varies by market.
7. Are there side effects?
Possible side effects include headache, nausea, elevated liver enzymes, and an increased risk of blood clots in some patients. Patients require regular monitoring.
8. Can children take Revolade?
In some countries, Revolade is approved for pediatric patients with specific forms of ITP. Eligibility depends on age, diagnosis, and local prescribing information.
9. Can I buy Revolade online?
Revolade is a prescription-only medicine and should only be obtained through licensed pharmacies and authorized healthcare channels in accordance with local laws.
10. Why choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. aims to provide high-quality pharmaceutical products backed by quality standards, regulatory support, and reliable global distribution
Keywords
